Marketresearchnews

Wednesday, 2 September 2020

Immunoassay in R&D Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Immunoassay in R&D Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Global Immunoassay in R&D Market: Increasing investment in research and development activities coupled with the growing prevalence of chronic diseases is likely to boost the market growth during the forecast period

Market Overview

In this MRFR market note, the global immunoassay in R&D market is discussed at length. Market Research Future (MRFR) forecasts a CAGR of 8.18% for global immunoassay in R&D market from 2018 to 2023. Immunoassays are analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays incorporate a variety of different labels for the detection of antibodies and antigens. These labels are generally chemically linked or conjugated to the desired antibody or antigen. Immunoassays are majorly used in various areas of pharmaceutical research such as therapeutic drug monitoring, and bioequivalence studies in drug discovery, among others.

Also Read : https://www.globenewswire.com/news-release/2019/07/30/1893542/0/en/Immunoassay-in-R-D-Market-Value-to-Surpass-USD-7-716-6-Million-Revenue-Mark-by-2023-at-8-18-CAGR-Says-Market-Research-Future.html

Competitive Analysis

The prominent players in the global immunoassay in R&D market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), bioMérieux Inc. (France), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan) and Abcam PLC (United Kingdom).

Segmentation

The global immunoassay in the R&D market has been segmented into type, application, and end user. By type, the market has been categorized as Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), Radioimmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmunoassay, and others. Based on application, the market has been divided into infectious diseases, cancer research, endocrinology, autoimmune diseases, and others. By end-user, the market has been segregated into pharmaceutical and biotechnology companies, academic institutions and laboratories, and others. The pharmaceutical and biotechnology companies segment accounted for a market value of USD 1,742.6 million in 2017.

Kits and reagents to dominate the global immunoassay in R&D market on the basis of products and services

Kits and Reagent segment is expected to continue leading the global market. Assay kits and reagents are the basic tools used in the research process. Several companies offer kits that simultaneously can detect more than one indication. This segment is anticipated to grow at a CAGR of 9.03% during the assessment period.

ELISA segment to be major type in the global immunoassay in R&D market

Enzyme-Linked Immunosorbent Assay (ELISA) is a sensitive method to test for the presence of antigen or ligand. This test is mostly used to detect HIV/AIDS. The segment is expected to grow with a CAGR of 7.57% during the forecast period.

Regional Analysis

The global immunoassay in the R&D market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global immunoassay in the R&D market during the forecast period. This is attributed to the increasing number of research projects in laboratories, as research laboratories play a vital role in the growth of the regional market. Besides, several research grants are given by governmental agencies. The European market for immunoassay in R&D is expected to be the second largest during the forecast period. The growing adoption in diagnostic measures is expected to boost the growth of the market in this region.

Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth. Asia-Pacific is estimated to be the fastest growing market due to the developing healthcare infrastructure and increasing disposable income. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the Asia-Pacific region, South Korea accounted for a market share of 10.1% in 2017. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.

Infectious disease segment will dominate the application segment

The increase in the prevalence of infectious diseases is expected to boost the growth of the segment. For instance, according to the statistics published in 2015 by the National Center for Health Statistics (NCHS), the number of visits to physician offices for infectious and parasitic diseases were 16.8 million in the US. The segment is expected to grow with a CAGR of 10.16% during the forecast period.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/immunoassay-in-r-d-market-7892

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Live Cell Encapsulation Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Live Cell Encapsulation Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Research Future (MRFR) estimates that the global live cell encapsulation market is expected to register a CAGR ~ 3.22% during the forecast period of 2018 to 2023, with an estimated market value of USD 249.87 million in 2017.

Market Overview

Numerous factors such as a high level of research activities in live cell encapsulation technologies and the rising awareness programs in various countries are anticipated to fuel the growth of the market. Moreover, the increasing investments by various public and private organizations have created a lucrative option for many companies to invest in providing new encapsulation techniques, leading to the overall growth of the market. Furthermore, the inclination towards novel drug delivery systems for disease management fuels the growth of the market during the forecast period.

Also Read : https://www.globenewswire.com/news-release/2019/07/30/1893564/0/en/Live-Cell-Encapsulation-Market-Size-to-Grow-at-3-22-CAGR-Forecast-2018-2023-Industry-Analysis-by-Manufacturing-Technique-Polymer-Type-and-Application-Prediction-by-MarketResearchFu.html

However, the lack of skilled technicians, and ethical and legal issues, and unaffordability of various small-scale companies to enter the market due to high product manufacturing costs are expected to curb the growth of live cell encapsulation market. Moreover, the availability of high-quality raw material is also restraining the growth of the market.

The global live cell encapsulation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in August 2018, Balchem Italia S.r.l., a wholly owned subsidiary of Balchem Corporation, acquired Bioscreen Technologies, S.r.l., a privately held manufacturer of encapsulated and fermented feed nutrition ingredients. With this, the company aims to expand its position in the market.

Competitive Analysis

Some of the key players in the global live cell encapsulation market are Evonik Industries, Balchem Corporation, Biotime, Inc., Blacktrace Holdings Ltd., Sigilon Therapeutics, Inc., BÜCHI Labortechnik AG, Encapsys, LLC, Lycored, MiKroCaps, Living Cell Technologies, Merck KGaA, Reed Pacific Pty Limited, Neurotech Holdings, LLC, Sernova Corporation, and Viacyte, Inc.

Segmentation

The global live cell encapsulation market has been segmented into manufacturing technique, polymer type, and application. The market, based on manufacturing technique, has been segmented into simple dripping, electrostatic dripping, coaxial airflow, rotating disk atomization, and others. The market, by polymer type, has been further segmented into alginate, HEMA-MMA, Chitosan, silica, cellulose sulfate, PAN-PVC, and others. The market, by application, has been segmented into drug delivery, regenerative medicine, cell transplantation, and others.

Regional Analysis

The market in the Americas is expected to dominate the global live cell encapsulation market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Europe is expected to hold the second largest position in the global live cell encapsulation market. The market growth in this region is because of the presence of a well-established healthcare system and increase in life-threatening diseases. For instance, according to cancer research UK, there were approximately 9,921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for the use of new techniques such as encapsulation as well as an increase in the market demand for cellular research. These factors are expected to have a positive impact on the live cell encapsulation market. Asia-Pacific is estimated to be the fastest growing region in the market due to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. The market in the Middle East & Africa is likely to account for the smallest share of the global Live Cell Encapsulation Market. The market growth in this region owes to the low disposable income in the region.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/live-cell-encapsulation-market-7772

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Smart Biosensors Market Will Generate An Enormous Revenue Till 2023| Market Research Future

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Smart Biosensors Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Global Smart Biosensors Market accounted for USD 12,000 million and expected to register 7.64% CAGR during the forecast period (2018–2023), according to the latest research report from Market Research Future (MRFR).

Market Overview

Smart biosensors are advance analytical devices used to detect the chemical and biological substance and helps to understand and analyze the nature of the biological structure. Smart biosensors are more compatible, easy to carry and more accurate than traditional devices.

The factors propelling the growth of the global smart biosensors market are the rising prevalence of diabetes in developing economies, increasing demand for advanced monitoring systems, and raising awareness about advance biosensors. However, the high costs associated with smart biosensors, side effects of insulin pens, and the growing popularity of other substitutes such as insulin pumps may hamper market growth during the assessment period.

Also Read : https://www.globenewswire.com/news-release/2019/07/31/1894228/0/en/Smart-Biosensors-Market-to-Exceed-USD-12000-million-Revenue-by-2023-Industry-Driven-by-Favorable-regulatory-policies-and-increasing-awareness-about-biosensors-Predicts-Market-Resea.html

Competitive Analysis

Some of the key players in the global smart biosensors market are Abbott Point of Care Inc., Medtronic Inc., F. Hoffman La-Roche Ltd., Siemens Healthcare AG, Lifescan, Inc., LifeSensors Inc., Nova Biomedical Corp., Acon Laboratories Inc., Universal Biosensors, Pharmaco-Kinesis Corporation, Biacore, and Others

Segmentation

The global smart biosensors market has been segmented on the basis of product type, technology, application, and end user.

On the basis of product type, the market has been classified as wearable biosensors, non-wearable biosensors.

The technology segment has been divided into electrochemical biosensors, piezoelectric biosensors, optical biosensors, thermal biosensors, nanomechanical biosensors, and others. Thermal biosensors segment is likely to be the fastest growing segment during the forecast period.

Based on application, has been segmented into blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others.

The end user segment has been divided into point-of-care, home diagnostics, research labs, security & biodefense, environmental monitoring, food & beverage industry, and others.

Regional Analysis

In the Americas, the North American market is likely to hold the majority share of the Smart Biosensors Market owing to the increasing prevalence of chronic disorders, favorable policies implemented by government and regulatory authorities, and adoption of highly advanced technology. According to the American Diabetes Association, in 2015, more than 30.3 million diabetes patients were present in America, the number is equivalent to 9.4% of the total population. The US is expected to account for the largest share of the North American market during the forecast period owing to the presence of major market players such as Medtronic, F. Hoffman La-Roche Ltd., Siemens Healthcare AG, and Lifescan, Inc.

The global smart biosensors market is currently dominated by several players. The market players are engaged in strategic collaborations and acquisitions to expand their product portfolios. For instance, In February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with the company’s Agile R100 protein assay system to increase the

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/smart-biosensors-market-7801

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Imaging Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Veterinary Imaging Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Global Veterinary Imaging Market size is projected to touch USD 1800 Mn by 2023, exhibiting a 6.90% CAGR from 2018 to 2023 (forecast period), according to a new report published by Market Research Future (MRFR). The focus on pet health has brought veterinary imaging to the forefront. Veterinary imaging has evolved with the latest diagnostic techniques capable of detecting cysts or major issues in the nick of time. Emergence of veterinary imaging clinics, veterinary clinics, and animal care providers is expected to boost market growth over the forecast period.

Also Read : https://www.globenewswire.com/news-release/2018/08/08/1548804/0/en/Veterinary-Imaging-Market-Size-and-Share-Projected-to-Reach-USD-1800-Mn-by-2023-Market-Research-Future.html

Rise in numbers of pet owners and emergence of animal healthcare brands offering imaging equipment at cost-effective prices are factors likely to fuel market demand. Growing incidence of zoonotic diseases can act as a tailwind for the market, expanding the market potential even further. According to a report by the Maine Center for Disease Control & Prevention, three-fourths of zoonotic diseases can affect humans as well. Preventive care taken at initial stages by pet lovers coupled with government campaigns to create awareness of testing can bode well for the market in the coming years. Reimbursement schemes designed for animals can work favorably for the market as well. But the expensive nature of imaging tests can be a headwind for the market.

Top Players Overview:

Notable players in the veterinary imaging market include Esaote SpA, Medical Imaging/IMCO, Inc., Hallmarq Veterinary Imaging Ltd., Heska Corporation, Canon Inc., General Electric, BCF Technology, Ltd., Merry X-Ray, Idexx Laboratory Inc., Carestream Health, Fujifilm Holding Corporation, Diagnostic Imaging System, Inc., and others.

Partnerships are abounding in the market with industry leader Heska, a U.S. company, joining hands with Pathway Vet Alliance in 2018 to enhance offerings of veterinary care nationwide. The technology of Heska can streamline the workflow within the network of veterinary clinics owned by Pathway. Animal health charities are providing funding to expedite research and development on canine health. The results can be instrumental in providing rapid diagnosis and treatment and allaying fears of pet owners.

Veterinary Imaging Market Segmentation:

The Global Veterinary Imaging Market is segmented by product type, animal type, therapeutic area, end-user, and region. Types of products in the market include instruments, veterinary imaging reagents, and veterinary software. The instruments segment is expected to generate maximum demand owing to its accuracy and cost-effectiveness. Magnetic resonance imaging systems, computed tomography imaging systems, ultrasound imaging systems, radiography (X-ray) systems, and others are grouped in the instruments segment. Within this, the radiography segment accounted for the largest market share. But the veterinary software segment is anticipated to grow robustly over the forecast period owing to its compatibility with animal imaging devices.

Animal types which can be diagnosed include small companion animals, large animals, and others. The small companion animal segment can exhibit a strong growth rate owing to increasing adoption of pets. Demand for high-quality healthcare by pet owners is projected to bolster segment growth over the forecast period.

Therapeutic areas utilizing the benefits of veterinary imaging include neurology, cardiology, oncology, orthopedics & traumatology, and others. The orthopedics & traumatology segment is the biggest followed by cardiology. This segment can thrive owing to grievous bone injuries by farm animals as well as companion animals. Rising cases of heart problems is anticipated to spur the cardiology therapeutic segment over the forecast period. The neurology segment can also experience a significant growth spurt owing to nervous system and brain disorders.

Major end-use sectors comprise hospitals & clinics, academic institutes, and others. The hospitals & clinics segment is expected to account for a lion’s share of the market owing to being a frequent hub for imaging tests. The academic institutes segment can grow at the fastest rate thanks to increased budget provided to expedite development of diagnostic imaging techniques.

Veterinary Imaging Market Regional Overview:

Regions discussed include North America, South America, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe. The North and South America markets collectively accounted for a large share of the market in 2017. Rise in pet ownership numbers, adoption of purebreds, and disposable incomes of consumers are factors expected to constantly drive the market growth. Pet insurance in Canada and the U.S. can be a plus for these markets. The Europe market holds the second spot, followed by APAC. Investments by market giants, adoption of advanced technology, and strong pet ownership rates are playing a crucial role in fueling market growth.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

3D Printing Medical Devices Market Staggering Double Digit Cagr Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “3D Printing Medical Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

A study by Market Research Future (MRFR) reports that the Global 3D Printing Medical Devices Market is likely to witness exponential growth over the forecast period 2018 to 2023. The market is likely to expand at an approximate CAGR of 18% over the forecast period.

In dental and medical device manufacturing, 3D printing medical devices has a critical role to play. Apart from the healthcare industry, 3D printing medical devices find wide application in other sectors as well that include automotive parts, food, and household items. Several therapies also make use of the 3D printing technology which includes the formation of limb prosthetics, plastic tracheal splints, titanium alternatives for hips & jaws etc. Owing to the simplified usage of the devices and progressive technology many doctors opt for 3D printing devices before conducting surgery of any part of the body. 3D printing medical devices help in eliminating errors in such cases.

Also Read : https://www.globenewswire.com/news-release/2019/07/26/1892320/0/en/3D-Printing-Medical-Devices-Market-2019-Shows-Progressive-Expansion-at-18-CAGR-by-Top-10-Global-Players-with-Forecast-to-2023.html

Growth in the worldwide 3D Printing Medical Devices Market is likely to propel at an increasing rate owing to the progressive technology, surging government spending in healthcare sector, increasing usage of 3D printing medical devices in the healthcare sector, and the simplified process of manufacturing the 3D printing medical devices.

The cost effectiveness of the 3D printing medical device makes it popular amongst major medical device manufacturers. They use it in manufacturing prostheses, custom made knee, hip implant, and hearing aids. The 3D printing medical devices market has the potential to grow exponentially due to the constant technological upgradations taking place in the industry, fast paced customer base, investment in research and development, and growing scope for biomedical application options.

However, the high-priced printers, restricted technical skills in medical devices, biocompatibility concerns related to 3D printed medical devices, and often unfavorable reimbursement policies are likely to hinder the market growth substantially.

Key Players

The global 3D printing medical devices market has been dominated by key players such as

3T RPD Ltd.
3D Systems Corporations
Bio3D Technologies
Arcam AB
Cyfuse Medical K.K.EOS GmbHConcept
EnvisionTEC, Materialise NV
Laser GmbH
Oxford Performance Materials, Inc.
Organovo Holdings, Inc.
Prodways Group
Renishaw plc
SLM Solutions Group AG
Stratasys Ltd.

Market Segmentation

The worldwide 3D printing medical devices market has been segmented based on component, types, application, end-users, and technology.

Based on component, the global market has been segmented into materials software & services, system, 3D printer, and 3D bio printer. Software & services holds the largest share of 3D printing medical devices market in forecast period.

Based on types, the global market has been segmented into surgical instruments, surgical guides, tissue engineering product, and prosthetics & implants.

Based on application, the global market has been segmented into clinical study devices, external wearable devices, tissue engineering, and implants.

Based on end-users, the global 3D printing medical devices market has been segmented into medical, hospitals, biotech and pharma companies, surgical centers, contract research organization, and academic institutions.

Based on technology, the global market has been segmented into droplet deposition, 3D printing, laser beam melting, photopolymerization, polyjet technology, laminated object manufacturing (LOM), electron beam melting (EBM), and others.

Regional Analysis

Geographically, the global 3D Printing Medical Devices Market has been segmented into Europe, the Americas, Asia-Pacific, and the Middle East & Africa.

North America is likely to lead the global 3D printing medical devices market over the forecast period. Factors affecting the growth in this region include surging government outlay towards research and development activities and expanding demand for organ transplant surgeries in the region. Europe holds the second position in the global market. The Europe market has favorable government spending in the research and development activities. The growing prevalence of diabetes registers Asia-Pacific as one of the most lucrative markets while the Middle East & Africa records the least market share owing to the inadequate healthcare facilities available in the region.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Venous Blood Collection Devices Market Staggering Double Digit Cagr Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Venous Blood Collection Devices Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Research Future (MRFR) states that the worldwide venous blood collection devices market is likely to develop at a CAGR of 9.3% over the forecast period of 2017-2023.

Market Overview

Venous blood collection devices consist of holders, needles, collection tubes, and other devices which find wide application in collecting blood samples. They extend protection against radiation and contamination apart from offering mechanical protection. The worldwide venous blood collection devices market growth has been upheld primarily by increasing demand for diagnostic services. The prevalence of global chronic diseases is expanding at an alarming pace which persuades high demand for screening services and subsequently surges the development of the worldwide venous blood collection devices market. This situation has been complemented by increasing health awareness and rising disposable income among consumers. Medical device manufacturers are endeavoring towards product improvement in order to meet the soaring demand. This has resulted in the requirement of progressive venous blood collection devices which can be used for safer blood collection. Additionally, development in product portfolio by notable medical device manufacturers have resulted in the merging of the worldwide venous blood collection devices market.

Also Read : https://www.globenewswire.com/news-release/2019/07/26/1892127/0/en/Venous-Blood-Collection-Devices-Market-Striking-a-CAGR-of-9-3-By-2023-Increasing-Disposable-Income-Has-Been-Playing-a-Key-Role-in-Influencing-the-Global-Venous-Blood-Collection-Dev.html

However, the market growth can be restricted by risks linked to pricing pressure, inferior quality product from local manufacturers, and contamination.

Competitive Analysis

The global venous blood collection devices market has been dominated by prominent players such as Narang Medical (India), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Vital Diagnostice (ELITech Group) (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), Sekisui Chemical Co., Ltd. (Japan), Sarstedt AG & Co (U.S.), CDRICH (China), Hongyu Medical (China), Qiagen NV (Netherlands), Improve Medical Technology Co. Ltd. (U.S.), Bio-Rad Laboratories, Inc. (U.S), Soya Green Tec Co., Ltd. (South Korea), NIPRO Medical Corporation (Japan), Medtronic Plc (U.S.), KHB (U.S.), SanLI (Myanmar.), Greiner Bio One International GmbH (Greiner Group) (Austria), Terumo Medical Corporation (Japan), Biosigma (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), F.L. Medical (Italy), Becton, Dickinson and Company (U.S), and Kabe Labortechnik GmbH (Germany).

Segmentation

The worldwide venous blood collection devices market has been segmented based on material, type, end user, and application.

By material, the worldwide venous blood collection devices market has been segmented into glass, ceramic, stainless steel, plastic, and others.

Based on type, the global venous blood collection devices market has been segmented into microfluidic system, vacuum blood collection system, micro-hematocrit tubes, needles, micro-container tubes, blood collection tubes, warming devices, and others. Other venous blood collection devices comprise blood bags and venous cannula.

Based on end user, the worldwide Venous Blood Collection Devices Market has been segmented into point of care, hospitals and clinics, diagnostic centers, blood donation centers, and others.

Based on application, the worldwide venous blood collection devices market has been segmented into intraoperative blood salvage and vein blood gas sampling. The vein blood gas sampling segment has been sub-segmented into acid-base status monitoring and diagnosis of disease.

Regional Analysis

The Americas represents the most substantial market share of the worldwide venous blood collection devices sector. Wide-ranging usage of screening methods in the developed nations, increasing healthcare spending, and rapid adoption of new medical devices drive the growth of the market in the Americas. Likewise, the promising repayment landscape in the region propels the market growth to a notable extent.

APAC market has been driven by the developed owing to the healthcare sector in the region, particularly in developing economies such as India, China, and Japan. Increased demand for safe blood assortment equipment, growth in geriatric population, and increasing inclination towards disposable items in laboratories can be considered accountable factors for the development of the APAC market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Anti-hypertensive Drugs Market Statistical Analysis In 2019 By International Top 10 Players Till 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Anti-hypertensive Drugs Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Anti-hypertensive Drugs Market is expected to experience a moderate CAGR of 2.67% during the forecast period (2018-2023) with the valuation touching USD 41,123.2 million by the end of 2023.

An uptick in the lifestyle, triggered by jet-speed urbanization and industrialization, at times reveal a few clefts. The change takes people afar from the root which can adversely impact the body. One such is hypertension or high blood pressure. If allowed to persist longer, then it has the potential to lead to much more demanding diseases such as heart failure, stroke, peripheral vascular disease, chronic kidney disease, and others. To counter the disease, anti-hypertensive drugs have been introduced by various drug manufacturers. These drugs are primarily chemicals that can lower high blood pressure or tension and curb chances of contracting myocardial infarction or stroke.

Also Read : https://www.globenewswire.com/news-release/2019/04/11/1802463/0/en/Anti-Hypertensive-Drugs-Market-to-Exceed-USD-41-123-2-Million-by-2023-at-2-67-CAGR-Say-Market-Research-Future.html

Key Players Locking Horns:

The anti-hypertensive drugs market is densely packed with several market titans who have engaged long in strategic battles to take over the market. This has created a perfect ambience for the anti-hypertensive drugs market to move forward. Companies such as Pfizer, Inc. (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), Daiichi Sankyo Company, Ltd. (Japan), United Therapeutics Corporation (U.S.), Sanofi S.A. (France), Johnson & Johnson Services, Inc. (U.S.), Merck KGaA (Germany), Takeda Pharmaceutical Company (Japan), Boehringer Engelheim GmbH (Germany), and Bayer AG (Germany) are impacting the market with their tactical moves.

Future Market Factors:

At present, the anti-hypertensive drugs market is substantially big and the coming days promise of a moderate growth with factors such as government initiatives and introduction of generics to back it up. Hypertension is a disease that is becoming quite common, even youths are displaying symptoms of it. This has led to initiatives undertaken by governments and NGOs across the globe to make people aware of symptoms and involve them in taking necessary measures. Several programs are getting planned to build up a robust network which integrates patients as a part of the entire setup. At the same time, the anti-hypertensive drugs market is getting traction due to the mass production of generic drugs which has lowered the cost of treatment substantially.

Segmentation:

The anti-hypertensive drugs market can be judged on the basis of several segmental analysis that convey both volume-wise and value-wise data. These segments are type, therapeutic class, and distribution channel.

Based on the type, the anti-hypertensive drugs market can be segmented into primary and secondary hypertension. As of 2017, the primary segment scored the most, a growth that was triggered by genetic factors and insulin resistance. Lifestyle changes can also be considered an elemental force in pushing the segment forward.

Based on the therapeutic class, the anti-hypertensive drugs market includes calcium blockers, ACE inhibitors, vasodilators, diuretics, renin inhibitors, beta-adrenergic blockers, ARBs, and others. The diuretics segment is expected to top the market in the coming years but the ACE inhibitors are expected to receive exponential CAGR during the forecast period.

By distribution channels, the anti-hypertensive drugs market can rely on online pharmacy, e- commerce websites & online drug stores, hospital pharmacy, retail pharmacy, and others. The retail pharmacy segment is cruising ahead with substantial market lead and prospect.

Regional Challenges:

The anti-hypertensive drugs market depends mostly on the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Region-specific analysis of the market reveals growth pockets that can be of great benefit for market players.

Presence of several major pharmaceuticals is just one of the many factors that is contributing substantially to the growth of the North American market. Other factors such as high awareness and better medical facilities are amply backing the region’s global supreme position. Structurally, the region is way ahead of its peers which is partnering well with reimbursement policies.

Europe has drivers similar to North America. The revenue that the regional market is generating is also helping them into developing strategies for further market expansion. For the companies in this region, the APAC is fast emerging as an alluring space where they are expanding their setups to increase the profit margin.

The APAC region gains mostly from its vast population which significantly possesses one of the largest patient pools globally. At the same time, several countries in the region are leaving out their cocoon to emerge as prominent economies. This has triggered in an overhauling of the prevalent setup. Healthcare sector is in the frontline that is gaining maximum benefits of such initiatives. As a host for foreign players, the region is making strategies well to take the market forward.

Changes to Change Trends:

In a recent article of the American Journal of Physiology, researchers claimed that lower level of zinc in the body can alter kidney function and increase blood pressure. The lack of it would affect kidney’s handling of sodium which would then trigger irregularity in proteins.

Hypertension Service and Hypertension Specialty Clinic, Brigham, recently started operating by providing their patients with a Bluetooth device and instructing them to check their blood pressure twice daily. Such an initiative lowered the hypertension symptoms in maximum patients as it allows doctors to alter medications in time. The process is cost-effective and uses precious hours to save lives.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com